컨슈머 헬스케어 시장 : 제품별, 유통별 - 세계 예측(2025-2030년)

The Consumer Healthcare Market was valued at USD 333.03 billion in 2023, expected to reach USD 356.94 billion in 2024, and is projected to grow at a CAGR of 7.38%, to USD 548.31 billion by 2030.

Consumer healthcare is a rapidly evolving segment of the healthcare industry, encompassing wellness products, OTC drugs, dietary supplements, and personal care items that consumers purchase for self-care. The necessity for consumer healthcare is driven by the increasing health awareness, rising prevalence of chronic diseases, an aging population, and a trend towards self-medication which reduces the burden on traditional healthcare services. The application of consumer healthcare products spans across preventive care, disease management, nutritional supplementations, and personal wellness, with end-use in individual households and retail consumers seeking convenient health solutions. Key growth influencers include technological advancements in product formulations, increased digital health literacy among consumers, and a shift towards holistic health and wellness approaches. Opportunities exist in leveraging digital platforms for direct-to-consumer sales and personalized health solutions. Furthermore, there's potential in expanding market reach through strategic partnerships with e-commerce giants and investing in data analytics to enhance consumer insights. However, challenges include regulatory hurdles, price sensitivity, and intense competition from generic and private-label brands, which may hinder growth. Companies should also be wary of misinformation that can arise from online health spaces, affecting consumer trust. Innovating in areas such as personalized nutrition, telehealth, and AI-driven health monitoring can offer competitive advantages, as can exploring sustainable and eco-friendly product lines in response to growing consumer demand for environmental responsibility. The nature of the consumer healthcare market is dynamic and consumer-centric, with an increasing emphasis on convenience and accessibility. Staying agile and responsive to changing consumer preferences and technological trends will be critical for sustained growth and success in this burgeoning market. Recommendations include investing in research and development to stay ahead of emerging health trends and committing to transparency in product information to build consumer trust.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Consumer Healthcare Market

The Consumer Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising geriatric population and inclination of consumers towards self-medication products
  • Government support to offer affordable and improved access to healthcare
  • Growing adoption of private labels consumer healthcare products
• Market Restraints
  • Availability of counterfeit products that lack active pharmaceutical ingredients
• Market Opportunities
  • Increasing approval rate of wellness and preventive medicines
  • Rapid growth of online pharmacies and improved availability through online platforms
• Market Challenges
  • Concerns associated with abuse and misuse of consumer healthcare products

Porter's Five Forces: A Strategic Tool for Navigating the Consumer Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Consumer Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Consumer Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Consumer Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Consumer Healthcare Market

A detailed market share analysis in the Consumer Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Consumer Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Consumer Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Consumer Healthcare Market

A strategic analysis of the Consumer Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Consumer Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, AMCO Proteins, American Health Inc., Amway Corporation by Alticor corporation, Axtria Inc., BASF SE, Bayer AG, Bionova Lifesciences by Pragati Biocare Pvt. Ltd., Boehringer Ingelheim International GmbH, Cipla, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, Endo Pharmaceuticals PLC by DuPont de Nemours, Inc., Gemini Pharmaceuticals Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Henin Lukinz Pvt. Ltd., Herbalife Ltd., Hetero Drugs Ltd., Himalaya Wellness Company, Iovate Health Sciences International Inc., Ipsen S.A., Johnson & Johnson Services, Inc., Koninklijke DSM N.V., Lonza Group Ltd., Lupin Limited, Mankind Pharma, MusclePharm Corporation, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Nature's Bounty, Inc. by Nestle S.A., Novartis AG, Omega Protein Corporation, Pfizer Inc., Piramal Group, Procter & Gamble Company, PureTek Corporation, QuestNutrition, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ventus Pharmaceuticals Private Limited, and Zoic Biotech Private Limited.

Market Segmentation & Coverage

This research report categorizes the Consumer Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Dietary Supplements and OTC Pharmaceuticals.
• Based on Distribution, market is studied across Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers, and Supermarkets or Hypermarkets.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising geriatric population and inclination of consumers towards self-medication products
    • 5.1.1.2. Government support to offer affordable and improved access to healthcare
    • 5.1.1.3. Growing adoption of private labels consumer healthcare products
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of counterfeit products that lack active pharmaceutical ingredients
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing approval rate of wellness and preventive medicines
    • 5.1.3.2. Rapid growth of online pharmacies and improved availability through online platforms
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with abuse and misuse of consumer healthcare products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Consumer Healthcare Market, by Product

• 6.1. Introduction
• 6.2. Dietary Supplements
• 6.3. OTC Pharmaceuticals

7. Consumer Healthcare Market, by Distribution

• 7.1. Introduction
• 7.2. Departmental Stores
• 7.3. Independent Retailers
• 7.4. Pharmacies or Drugstores
• 7.5. Specialist Retailers
• 7.6. Supermarkets or Hypermarkets

8. Americas Consumer Healthcare Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Consumer Healthcare Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Consumer Healthcare Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. SPE Capital acquires majority stake in Vital, the leading nutritional supplements company in Tunisia
  • 11.3.2. Nutrilitius expands portfolio with launch of new range of nutraceuticals, Unleashing the Power of Food Science & Technology
  • 11.3.3. LBB Specialties and DSM announce partnership for North America Dietary Supplements Distribution
  • 11.3.4. Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
  • 11.3.5. health supplements: Tata Consumer enters health supplements segment, launches plant protein powder
  • 11.3.6. Cipla Health to buy nutritional supplement brand Endura Mass
  • 11.3.7. Orkla Health acquires Healthspan
  • 11.3.8. Amway India launches nutrition supplements in gummies and jelly strips
  • 11.3.9. Wellbeing Nutrition raises $2.2 million led by Fireside Ventures
  • 11.3.10. Bayer launches Consumer Health division in India
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories Inc.
• 2. Alembic Pharmaceuticals Ltd.
• 3. Alkem Laboratories Limited
• 4. AMCO Proteins
• 5. American Health Inc.
• 6. Amway Corporation by Alticor corporation
• 7. Axtria Inc.
• 8. BASF SE
• 9. Bayer AG
• 10. Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
• 11. Boehringer Ingelheim International GmbH
• 12. Cipla, Inc.
• 13. Dr. Reddy's Laboratories
• 14. Eli Lilly and Company
• 15. Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
• 16. Gemini Pharmaceuticals Inc.
• 17. Glanbia PLC
• 18. GlaxoSmithKline PLC
• 19. Glenmark Pharmaceuticals Ltd.
• 20. Henin Lukinz Pvt. Ltd.
• 21. Herbalife Ltd.
• 22. Hetero Drugs Ltd.
• 23. Himalaya Wellness Company
• 24. Iovate Health Sciences International Inc.
• 25. Ipsen S.A.
• 26. Johnson & Johnson Services, Inc.
• 27. Koninklijke DSM N.V.
• 28. Lonza Group Ltd.
• 29. Lupin Limited
• 30. Mankind Pharma
• 31. MusclePharm Corporation
• 32. Mylan Pharmaceuticals Pvt. Ltd. by Viatris
• 33. Nature's Bounty, Inc. by Nestle S.A.
• 34. Novartis AG
• 35. Omega Protein Corporation
• 36. Pfizer Inc.
• 37. Piramal Group
• 38. Procter & Gamble Company
• 39. PureTek Corporation
• 40. QuestNutrition
• 41. Reckitt Benckiser Group PLC
• 42. Sanofi S.A.
• 43. Sun Pharmaceutical Industries Limited
• 44. Takeda Pharmaceutical Company Limited
• 45. Teva Pharmaceutical Industries Ltd.
• 46. Ventus Pharmaceuticals Private Limited
• 47. Zoic Biotech Private Limited